patients presented with aneurysmal subarachnoid hemorrhage (SAH), 23 with mass effect, and one with distal thromboembolism. Twenty-three patients presented with incidental aneurysms and four additional aneurysms were incidentally found in patients presenting with SAH from a second aneurysm. The 53 patients with SAH were subcategorized according to Hunt and Hess 15 grade: Grade I/II (36 patients), Grade III (eight patients), and Grade IV/V (nine patients). Thirty-six patients who suffered from SAH were treated within 2 weeks of their hemorrhage and nine of these patients were treated within 3 days of their hemorrhage.
Eighty-nine patients were considered at high risk for aneurysm surgery by the referring physicians because of poor medical condition (45 patients), aneurysm location (19 patients), unsuccessful previous surgical attempt (20 patients [ Table 1 ]), aneurysm size (two patients), or aneurysm morphology (three patients). Eleven patients refused surgery. On the basis of angiographic data at the time of embolization, the aneurysms were classified by size and neck width. The method used for such measurements has been published previously. 5 Fifty aneurysms were small (diameter Ͻ 15 mm), 29 were large (diameter 15-25 mm), and 25 were giant (diameter Ͼ 25 mm). Thirty-four aneurysms had small necks (Յ 4 mm), 65 had wide necks (Ͼ 4 mm), and five aneurysms were fusiform. Fifty-one aneurysms were located in the posterior circulation and 53 arose from the anterior circulation. More specifically, the most common location was the basilar apex (30 aneurysms), followed in descending order by the carotidophthalmic area (16) , posterior communicating artery (14) , vertebrobasilar junction (six), middle cerebral artery (six), cavernous internal carotid artery (six), posterior inferior cerebellar artery (four), anterior communicating artery (four), P 1 segment of the posterior cerebral artery (three), superior cerebellar artery (three), internal carotid artery terminus (three), anterior inferior cerebellar artery (two), paraophthalmic artery (two), basilar trunk (one), P 2 segment of the posterior cerebral artery (one), A 1 and A 2 segment of the anterior cerebral artery (one each), and an aneurysm arising from a persistent trigeminal artery (one).
At the initial sessions a total of 562 coils (total length 129 m) were placed in these 100 patients, for an average of 5.6 GDCs per patient (minimum one coil, maximum 36 Clinical follow-up data were collected from November 1995 through May 1996. Methods for obtaining the follow-up data were influenced by the patients' region or country of residence: 57 patients were from the local population; 23 lived in a different region of the United States; eight were from either Central America or South America; eight were from Italy; and four were from other countries. Follow up consisted of direct clinical examination (27 patients), updated clinical reports of the referring physician (27 patients), or telephone conversation with the patient (29 patients) or the patient's family (11 patients). Six patients were lost to follow up; all six were in excellent or good neurological condition at the last available examination. It was possible to obtain midterm follow up (Ն 2 years) in 94 patients. The follow-up period ranged from 2 to 6 years, with an average of 3.5 years. Clinical outcome was graded according to a modified Glasgow Outcome Scale 16 ( Table 2 ). In case of patient death, every effort was made to determine the cause of death precisely; an autopsy was performed when possible. If a death proved to be unrelated to the embolized aneurysm and occurred before midterm follow up was achieved (six patients [ Table 3 ]), the patient was dropped from analysis of midterm outcome. If a death proved to be unrelated to the embolized aneurysm and occurred after midterm follow up was achieved (two patients [ Table 3 ]), the patient's clinical status was listed as the clinical status preceding the unrelated death. Midterm status is thus available for 88 patients. In 20 patients who underwent subsequent surgical or endovascular non-GDC procedures, clinical outcomes were analyzed both immediately before the subsequent procedure and following that procedure, at midterm follow up.
Results

Clinical Outcome in 88 Patients With Midterm Follow-Up Review
At the midterm follow-up review, 57 patients (65%) enjoyed excellent outcomes, 11 (13%) had good outcomes, six (7%) had fair outcomes, three (3%) had poor outcomes, and 11 patients (13%) were dead. Seven of the deaths occurred in patients who presented with a Grade IV or V SAH and the other four deaths occurred in patients with giant aneurysms. If we compare neurological status at midterm follow up to pretreatment status, 72 patients (82%) were improved or remained unchanged, five (6%) were worsened, and 11 (13%) were dead.
This population encompasses three disparate groups: 1) patients presenting comatose from severe SAH; 2) patients whose post-GDC embolization course included subsequent surgery or parent vessel balloon sacrifice; and 3) patients who had GDC embolization as their definitive treatment. The results of each group are analyzed separately.
Clinical Outcome in Patients Who
Presented With Severe SAH. Of the nine patients treated in the acute stage of Grade IV or V SAH, seven died, one had a poor midterm clinical outcome, and one had a fair outcome. There has been no case of post-GDC embolization hemorrhage in this group. One of the seven patients who died underwent surgical treatment after GDC embolization.
Clinical Outcome in Patients Who Underwent Subsequent
Surgical or Endovascular Procedures. Seventeen patients underwent surgery subsequent to GDC embolization (Table 4). There was no case of post-GDC embolization aneurysm hemorrhage in this group. Surgery was performed for incomplete thrombosis of the aneurysm (nine patients), mass effect (six patients), removal of coils that had herniated into the parent vessel (one patient), and coil migration that occurred during the initial GDC procedure (one patient). Surgery consisted of aneurysm clipping with sparing of the parent vessel in nine cases and sacrifice of the parent vessel in eight cases.
Three patients underwent endovascular balloon sacrifice of the parent vessel after GDC embolization. Indications were incomplete aneurysm thrombosis in two patients and coil herniation into the parent vessel in one patient.
In these 20 patients, clinical outcome after GDC embolization, but before additional intervention, was defined as excellent or good in 14 cases (70%), fair in one case (5% [one patient with a giant basilar tip aneurysm and worsened mass effect after GDC embolization]), and poor in four cases (20% [two patients with giant basilar tip aneurysms with worsened mass effect after GDC treat- ment, one patient with a Grade IV SAH from a ruptured vertebrobasilar junction aneurysm, and one patient with a carotidophthalmic aneurysm who underwent surgery 2 hours after GDC deposition in the parent artery]). The midterm outcome (after additional intervention) was excellent or good in 15 patients (75%), fair in one patient (5%), and poor in one patient (5%). There were two operative deaths (10%). One patient is currently lost to follow up.
Clinical Outcome in Patients Who
Had GDC Embolization as Their Definitive Treatment. Midterm clinical follow up was obtained in 61 patients who underwent GDC embolization as their definitive treatment (Table 5) . Fortysix patients (75%) enjoyed excellent outcomes, seven (11%) had good outcomes, three (5%) had fair outcomes, one (2%) had a poor outcome, and four (7%) died.
All four deaths occurred in patients with giant, inoperable, previously unruptured, partially thrombosed aneurysms that bled 12 to 20 months after incomplete GDC treatment. There were two nonfatal incidences of bleeding, occurring 33 and 30 months, respectively, after incomplete GDC treatment (one giant and one large aneurysm). In these two patients, additional GDC treatment was performed with good and poor outcomes, respectively. Thus, the midterm incidence of post-GDC embolization hemorrhage in small aneurysms was 0%, whereas in large aneurysms it was 4% (one case in which the patient had previously undergone a failed surgical exploration). In contrast, the post-GDC embolization hemorrhage rate in giant aneurysms was 33% (five cases). Neurological status at midterm follow-up review in these 61 patients who underwent GDC as their definitive treatment was classified as improved or unchanged in 54 patients (89%), worsened in three patients (5%), and death in four (7%). Worsening occurred because of intraprocedural thromboembolic complications, whereas the four patients who died, as already mentioned, had giant lesions.
Aneurysm size had a significant effect on midterm clinical outcome (Table 5) . Patients with small aneurysms had a 93% incidence of excellent or good outcome. There were no deaths among the patients with small aneurysms. Patients with large aneurysms fared similarly well, with a 95% incidence of excellent or good outcome, only a single case (5%) of poor outcome, and no deaths. In contrast, 50% (five of 10 cases) of patients with giant aneurysms had excellent or good outcomes and 40% (four cases) died from post-GDC embolization hemorrhage. Ninety-seven percent of patients with small aneurysms and 95% of patients with large aneurysms had a midterm neurological status that was either improved or unchanged from their status at treatment. Only 50% of patients with giant aneurysms fared so well at midterm follow-up review.
Discussion
The endovascular treatment of intracranial aneurysms with the GDC system was introduced in the clinical setting in 1990. 10 Although it remains a relatively new procedure, its safety and efficacy in preventing early rebleeding have been proved in previous series. 8, 9, 11, 12, 14, 20, 21, [23] [24] [25] [26] Two main issues remain to be addressed regarding this technique: 1) the durability of the procedure; and 2) whether or how GDC embolization affects the subsequent incidence of vasospasm in ruptured aneurysms. Our analysis of clinical status 2 to 6 years after treatment with GDCs helps address the issue of durability over the midterm period.
Relationship Between Aneurysm Presentation and Clinical Outcome
Patients whose aneurysms were incidentally detected had the greatest chance of having an excellent or a good midterm clinical outcome (100% [20 of 20 patients with midterm follow up]) ( Table 6 ). Of these 20 patients, two required additional treatment because of coil herniation into the parent vessel. Both patients had excellent midterm outcomes.
Patients presenting with Grade I or II SAH had a 91% chance of having an excellent or a good midterm outcome (29 of 32 patients with midterm clinical follow up). Six of these patients underwent subsequent surgery 4 to 26 months after GDC embolization for incomplete thrombosis of the aneurysm. One of the 32 patients suffered hemiplegia and aphasia as the result of an intraoperative complication during a failed surgical clipping attempt before (7) 2 (7) 0 (0) 0 (0) 29 (97) (75) 7 (11) 3 (5) 1 (2) 4 (7) 54 (89) 7 (11) * Worsened outcome was due to intraprocedural thromboembolic complications. (13) 2 (6) 1 (3) (21) 2 (11) 1 (5) 4 (21) TIAs (1 patient) 1 (100) 0 (0) 0 (0) 0 (0) 0 (0) total (88 patients) 57 (65) 11 (13) 6 (7) 3 (3) 11 (13) * Includes 19 patients who underwent post-GDC surgical or endovascular procedures as further treatment for their aneurysms. See Table 4 for a description of these patients, including their clinical status before the subsequent procedure. See Table 2 for definitions of outcomes.
undergoing GDC embolization. This patient's aneurysm was subsequently treated endovascularly without incident. Two patients suffered thromboembolic complications during GDC embolization, resulting in a fair outcome in one and a poor outcome in the other. In both cases, the thromboembolic event occurred during preliminary angiography performed through a guide catheter before microcatheterization of the aneurysm. Both cases were atypical in that systemic heparinization was not used during the procedure.
Patients presenting with a Grade III SAH had an 86% chance of having an excellent or a good midterm outcome (six of seven patients). One of these six patients underwent subsequent surgery 4 months after the GDC procedure for incomplete thrombosis of the aneurysm. The seventh patient underwent subsequent surgery within 1 week of GDC embolization for mass effect from the coils placed in a giant basilar apex aneurysm. That patient improved somewhat after coil removal and aneurysm clipping, remaining in fair condition at the 2-year follow up.
From a technical standpoint, there were no particular difficulties encountered in performing early GDC embolization in patients with Grade IV or V SAH. Nevertheless, no patient who presented with SAH that severe had an excellent or good outcome, although one patient did improve to a fair outcome. Seven of the nine patients with Grade IV or V SAH died from complications of the initial hemorrhage, with no rebleeding.
Patients presenting with mass effect from their aneurysms had a 63% chance of having an excellent or a good midterm outcome (12 of 19 patients with midterm clinical follow up). Thirty-five percent of patients who presented with mass effect required a subsequent surgical or endovascular procedure. Although GDC embolization often improves the clinical symptoms of mass effect (53% in this series), it is not uncommon for mass effect to remain unchanged (26%) or, in giant lesions, to worsen (21%). In every case of small and large aneurysm (six patients), GDC embolization improved symptoms of mass effect. In contrast, symptoms of mass effect from giant aneurysms were less predictable in their response to GDC embolization, with approximately equal chances of improving (five cases), remaining unchanged (four cases), or even worsening (four cases). The mass effect on cranial nerves was more likely to improve after the GDC procedure (67% [six of nine cases]) than mass effect on the brain parenchyma (40% [four of 10 cases]). However, this may be an indirect reflection of aneurysm size because small and large aneurysms constituted 33% of cases with cranial nerve symptoms (such as diplopia and decreased visual acuity), but only 20% of cases with parenchymal symptoms (seizures or brainstem compression).
The Learning Curve
This series represents the first 100 GDC embolization procedures performed by our endovascular service. Over the last 6 years, our service and others have benefited from a continuous evolution in judgment, skills, strategies, and equipment in performing this procedure. Microcatheter improvements now allow secure positioning of the catheter tip within aneurysms previously inaccessible. New GDCs have been developed that are more flexible, have shorter detachment times, and are available in a greater range of lengths and radii, allowing more complete obliteration of aneurysms at the initial embolization procedure. The number of patients who were treated for giant lesions decreased from 25 in the first 100 patients to 16 in the second 100. The rate of complications with permanent sequelae dropped from 2% to 1% and the rate of fatal complications also dropped from 2% to 1%. Although the midterm follow-up time point has not been reached in our second 100 GDC patients, early data on this group indicate significant decreases in the number of patients requiring multiple GDC sessions (10% vs. 27%) and the number of patients undergoing subsequent additional non-GDC treatment (6% vs. 20%) ( Table 7) .
The clinical judgment, skills, and experience of the surgical team as well as technical advancements lead to a higher degree of aneurysm occlusion and lower complication rates. Achieving a complete aneurysm occlusion at the first session and closely following and retreating patients with subtotally occluded aneurysms are important factors in attaining consistent and adequate clinical results. 
Angiographic Follow-Up Review
Two-hundred nine follow-up angiogams were obtained in these 100 patients. In this early experience, routine follow-up angiograms were obtained in many patients 5 to 7 days after the GDC procedure (56 studies performed). This early angiographic follow-up review is no longer considered necessary and is not routinely performed. Patients who were in poor neurological grade at presentation and had poor outcomes in this series did not undergo follow-up angiography. The remaining 91 patients underwent follow-up angiography at 1 week to 3 months (35 studies), 3 to 12 months (69 studies), 12 to 24 months (33 studies), and more than 24 months after GDC treatment (16 studies).
The majority of aneurysms that showed persistent incomplete occlusion or compaction of coils on follow-up angiography were retreated with GDC embolization (Table 7, 27 cases) or surgery ( Table 4 , 11 cases). Subtotal aneurysm occlusion and the possible subsequent phenomenon of coil compaction are not unusual in wide-necked aneurysms. 5, 12 In small-necked aneurysms they constitute an uncommon occurrence.
Limitations of Comparing These Results With Surgical Series
In the 1990 landmark International Cooperative Study on the Timing of Aneurysm Surgery, Kassell and colleagues 17, 18 reported the 6-month outcomes in 3521 patients with aneurysmal SAH, 83% of whom had undergone surgery. They reported 68% excellent/good shortterm surgical results and 22% poor/dead short-term surgical results. Differences between this surgical patient population and our 53 SAH patients treated with GDC embolization include: 1) more posterior circulation aneurysms in the GDC series (66% vs. 8%); 2) fewer small aneurysms in the GDC series (66% vs. 78%); 3) more giant aneurysms in the GDC series (11% vs. 2%); 4) worse pretreatment neurological grade in the GDC series; 5) longer clinical follow-up period in the GDC series (3.5 years vs. 6 months); 6) a slightly greater time interval between hemorrhage and treatment in the GDC series; and 7) GDC patients had the benefit of the last decade's advances in understanding and management of acute aneurysmal SAH and cerebral vasospasm.
Miyaoka, et al., 22 published a series of 1622 patients with ruptured aneurysms, 80% of whom underwent surgery. The length and completeness of the follow-up review in that series were not specified. Overall outcome was similar to the International Cooperative Study 17, 18 with a 60% excellent/good outcome and a 27% poor/dead outcome. Giannotta and Litofsky 7 described 19 patients who underwent additional operations for recurrent or residual aneurysms 2 to 25 years after the inital surgery. Their experience reinforces earlier reports [1] [2] [3] [4] 6, 19, 27 that aneurysms can recur after clipping, even in cases in which postoperative angiography showed either no neck remnant or only a tiny neck remnant. Because the average lag time between initial treatment and recurrence of SAH or mass effect was 10 years, those authors emphasized that "the length and nature of follow-up must be adequate to ensure the future safety of the patient." Late repeated operation after incomplete surgical treatment of an aneurysm is technically daunting and is associated with higher rates of premature rupture (25% vs. 14% in primary aneurysm procedures) and permanent neurological deficits (16% moderate-to-severe disabilities). In contrast, GDC embolization appears more likely than surgery to require multiple sessions (27 in our first 100 patients, 10 in our second 100 patients), but the subsequent embolization procedures appear to carry significantly less risk (0% morbidity/mortality rates in this series) than repeated operation.
Finally, in this report patient outcome is defined in such a manner that it reflects the presence of any neurological deficit, including symptoms that predate any intervention. Although such a strict classification scheme (Table 2) is not universally observed in surgical series, it is a more accurate portrayal of patient outcome.
Conclusions
To review some of the salient findings of this study and their importance in evaluating the use of the GDC, we note the following: the procedure-related morbidity rate of GDC embolization in this entire series was 2%. If we were to exclude patients with Grades IV and V SAH, the rate was 0%. At midterm follow-up review, the post-GDC embolization hemorrhage rate for small aneurysms was 0%; for large aneurysms it was 4% (one case). Symptoms of mass effect from unruptured aneurysms resolved in all cases unless the aneurysm was giant. Excluding patients who presented with Grade IV and V SAH, 86% of patients with small or large aneurysms were in good or excellent neurological condition and 93% were either unchanged or improved from their pretreatment status. The results are less satisfactory in patients with giant aneurysms and all therapeutic options should be considered when facing cases with these formidable challenges. The need for multiple embolization sessions does not portend an unsatisfactory outcome. The need for repeated embolization procedures is more common than the need for repeated surgery; however, embolization is also easier and safer. In addition to the potential for a complete cure, GDC embolization can also prevent rebleeding and protect the aneurysm, allowing subsequent surgery.
It is our belief that these results are very encouraging. Two factors should also be considered: 1) the high-risk nature of this patient population (49% had posterior circulation aneurysms, 25% had giant aneurysms, 20% had previously failed surgery attempts, and 45% had severe medical problems); and 2) recent and important technical advancements in the GDC technique that were not available when these first 100 patients were treated. Overall, these patients had midterm outcomes that compare favorably with surgical series, although such comparisons are problematic at this point. A more definitive comparison between the results of aneurysm clipping versus GDC embolization-including safety, efficacy, and durabilitywill require a comparative study with long-term follow-up review and more sensitive and precise measures of outcome in both groups.
It is necessary to reiterate that clinical studies with longer follow-up time periods are necessary to assess the truly long-term durability of the GDC treatment modality.
